The Ivermectin Debate: Access vs. Caution

The Ivermectin Debate: Access vs. Caution

On this episode of Prescribed, Dr. Nathan Goodyear breaks down why the push for over-the-counter ivermectin must be met with clinical caution.

🧬 While ivermectin shows therapeutic potential, it is not without risk.

🩺 Every medication carries side effects—rare or not, they matter.

📊 A recent study highlights concerns that must guide thoughtful, personalized prescribing.

👨‍⚕️ As both an MD and homeopath, Dr. Goodyear calls for balanced judgment—not hype.

⚠️ Advocates may say it’s risk-free. That’s simply not true.

Watch the full episode on Prescribed to hear the clinical reality behind the headlines.

#PrescribedPodcast #DrNathanGoodyear #Ivermectin #OffLabelUse #FunctionalMedicine #MedicalFreedom #IntegrativeOncology #ClinicalJudgment #RepurposedMedications #PatientSafety #InformedCare